Comparing a new PET scan to standard vein sampling for adrenal disease
Part of Hormones & metabolism clinical trials.
This study compares a newer, less invasive PET/CT scan (using 68Ga-Pentixafor) to the standard adrenal vein sampling test to identify which adrenal gland is causing high blood pressure in people with primary aldosteronism. If you're considering surgery to remove a nodule on your adrenal gland, this trial may help determine the best approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old and have high blood pressure.
- Your blood tests show a high aldosterone-to-renin ratio (ARR), meaning your body makes too much aldosterone.
- You have a nodule (at least 1 cm) on one of your adrenal glands, seen on a CT or MRI scan.
- You're willing to consider surgery to remove the affected adrenal gland.
- You do not have other serious health issues like active cancer, severe heart disease, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan (68Ga-Pentixafor) to see if it can replace a more invasive blood test (AVS) for finding which adrenal gland is causing high blood pressure and high cortisol levels. It may help patients avoid a complicated procedure.
This trial compares different ways of doing adrenal vein sampling (a test to find which adrenal gland is causing high blood pressure). It aims to see if combining methods works better than using just one for people with primary aldosteronism.
This study uses a new type of PET scan (called Gallium-68 Pentixafor PET-CT) to help doctors better identify the source of a hormone problem causing high blood pressure. The goal is to see if this scan leads to better surgical outcomes compared to standard methods.
This trial tests a special PET scan (using a tracer called PentixaFor) to see if it can help find which adrenal gland is making too much aldosterone in people with primary aldosteronism. The goal is to reduce the need for more invasive tests like adrenal vein sampling.
This trial tests a special PET scan that may help doctors find the exact cause of high blood pressure related to an adrenal gland problem. It could help decide if surgery or medicine is the best treatment for you.
This trial tests a new imaging method called [18F]CETO PET scan to better understand the cause of high blood pressure due to primary aldosteronism (PA). It may help guide treatment decisions without needing more invasive tests.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.